Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Increased m-calpain expression in the mesencephalon of patients with parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?

Identifieur interne : 000254 ( France/Analysis ); précédent : 000253; suivant : 000255

Increased m-calpain expression in the mesencephalon of patients with parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?

Auteurs : A. Mouatt-Prigent [France] ; J. O. Karlsson [Suède] ; Yves Agid [France] ; E. C. Hirsch [France]

Source :

RBID : ISTEX:C99D9559849114DDA357418018F21B272E312E49

English descriptors

Abstract

Parkinson's disease is characterized by the loss of dopaminergic neurons in the substantia nigra and, to a lesser extent, the ventral tegmental area and catecholaminergic cell group A8. However, among these dopaminergic neurons, those expressing the calcium buffering protein calbindin are selectively preserved, suggesting that a rise in intracellular calcium concentrations may be involved in the cascade of events leading to nerve cell death in Parkinson's disease. We therefore analysed immunohistochemically the expression of the calcium-dependent protease calpain II (m-calpain) in the mesencephalon of patients with Parkinson's disease, progressive supranuclear palsy or striatonigral degeneration, where nigral dopaminergic neurons degenerate, and matched controls without nigral involvement. Calpain immunoreactivity was found in fibers and neuronal perikarya in the substantia nigra, the ventral tegmental area, catecholaminergic cell group A8 and the locus coeruleus. In patients with Parkinson's disease but not with the other neurodegenerative disorders, m-calpain immunoreactivity was detected in fibers with an abnormal morphology and in Lewy bodies. Sequential double staining revealed that most of these m-calpain-positive fibers and neuronal perikarya co-expressed tyrosine hydroxylase, indicating that most m-calpain neurons are catecholaminergic. Quantitative analysis of m-calpain staining in the substantia nigra and locus coeruleus revealed an increased density of fibers and neuronal perikarya in parkinsonian patients in both structures.These data suggest that increased calcium concentrations may be associated with nerve cell death in Parkinson's disease.

Url:
DOI: 10.1016/0306-4522(96)00100-5


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:C99D9559849114DDA357418018F21B272E312E49

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Increased m-calpain expression in the mesencephalon of patients with parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?</title>
<author>
<name sortKey="Mouatt Prigent, A" sort="Mouatt Prigent, A" uniqKey="Mouatt Prigent A" first="A." last="Mouatt-Prigent">A. Mouatt-Prigent</name>
</author>
<author>
<name sortKey="Karlsson, J O" sort="Karlsson, J O" uniqKey="Karlsson J" first="J. O." last="Karlsson">J. O. Karlsson</name>
</author>
<author>
<name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Yves Agid</name>
<affiliation>
<country>France</country>
<placeName>
<settlement type="city">Paris</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
<orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName>
</affiliation>
</author>
<author>
<name sortKey="Hirsch, E C" sort="Hirsch, E C" uniqKey="Hirsch E" first="E. C." last="Hirsch">E. C. Hirsch</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C99D9559849114DDA357418018F21B272E312E49</idno>
<date when="1996" year="1996">1996</date>
<idno type="doi">10.1016/0306-4522(96)00100-5</idno>
<idno type="url">https://api.istex.fr/document/C99D9559849114DDA357418018F21B272E312E49/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">002D40</idno>
<idno type="wicri:Area/Main/Curation">002963</idno>
<idno type="wicri:Area/Main/Exploration">002167</idno>
<idno type="wicri:Area/France/Extraction">000254</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Increased m-calpain expression in the mesencephalon of patients with parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?</title>
<author>
<name sortKey="Mouatt Prigent, A" sort="Mouatt Prigent, A" uniqKey="Mouatt Prigent A" first="A." last="Mouatt-Prigent">A. Mouatt-Prigent</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U289, Hoˆpital de la Salpêtrière, 47 bd de 1'h^opital, 75013 Paris</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Karlsson, J O" sort="Karlsson, J O" uniqKey="Karlsson J" first="J. O." last="Karlsson">J. O. Karlsson</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Institute of Neurobiology, University of Goteborg, P.O. Box 33031, S-400 33 Göteborg</wicri:regionArea>
<wicri:noRegion>S-400 33 Göteborg</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Yves Agid</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U289, Hoˆpital de la Salpêtrière, 47 bd de 1'h^opital, 75013 Paris</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
<placeName>
<settlement type="city">Paris</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
<orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName>
</affiliation>
</author>
<author>
<name sortKey="Hirsch, E C" sort="Hirsch, E C" uniqKey="Hirsch E" first="E. C." last="Hirsch">E. C. Hirsch</name>
<affiliation>
<wicri:noCountry code="no comma">To whom all correspondence should be addressed</wicri:noCountry>
</affiliation>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U289, Hoˆpital de la Salpêtrière, 47 bd de 1'h^opital, 75013 Paris</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Neuroscience</title>
<title level="j" type="abbrev">NSC</title>
<idno type="ISSN">0306-4522</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1996">1996</date>
<biblScope unit="volume">73</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="979">979</biblScope>
<biblScope unit="page" to="987">987</biblScope>
</imprint>
<idno type="ISSN">0306-4522</idno>
</series>
<idno type="istex">C99D9559849114DDA357418018F21B272E312E49</idno>
<idno type="DOI">10.1016/0306-4522(96)00100-5</idno>
<idno type="PII">0306-4522(96)00100-5</idno>
<idno type="ArticleID">96001005</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0306-4522</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>PSP</term>
<term>SND</term>
<term>calcium</term>
<term>cell death</term>
<term>dopamine</term>
<term>parkinsonism</term>
<term>protease</term>
<term>substantia nigra</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Parkinson's disease is characterized by the loss of dopaminergic neurons in the substantia nigra and, to a lesser extent, the ventral tegmental area and catecholaminergic cell group A8. However, among these dopaminergic neurons, those expressing the calcium buffering protein calbindin are selectively preserved, suggesting that a rise in intracellular calcium concentrations may be involved in the cascade of events leading to nerve cell death in Parkinson's disease. We therefore analysed immunohistochemically the expression of the calcium-dependent protease calpain II (m-calpain) in the mesencephalon of patients with Parkinson's disease, progressive supranuclear palsy or striatonigral degeneration, where nigral dopaminergic neurons degenerate, and matched controls without nigral involvement. Calpain immunoreactivity was found in fibers and neuronal perikarya in the substantia nigra, the ventral tegmental area, catecholaminergic cell group A8 and the locus coeruleus. In patients with Parkinson's disease but not with the other neurodegenerative disorders, m-calpain immunoreactivity was detected in fibers with an abnormal morphology and in Lewy bodies. Sequential double staining revealed that most of these m-calpain-positive fibers and neuronal perikarya co-expressed tyrosine hydroxylase, indicating that most m-calpain neurons are catecholaminergic. Quantitative analysis of m-calpain staining in the substantia nigra and locus coeruleus revealed an increased density of fibers and neuronal perikarya in parkinsonian patients in both structures.These data suggest that increased calcium concentrations may be associated with nerve cell death in Parkinson's disease.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
<li>Suède</li>
</country>
<region>
<li>Île-de-France</li>
</region>
<settlement>
<li>Paris</li>
</settlement>
<orgName>
<li>Hôpital de la Salpêtrière</li>
</orgName>
</list>
<tree>
<country name="France">
<region name="Île-de-France">
<name sortKey="Mouatt Prigent, A" sort="Mouatt Prigent, A" uniqKey="Mouatt Prigent A" first="A." last="Mouatt-Prigent">A. Mouatt-Prigent</name>
</region>
<name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Yves Agid</name>
<name sortKey="Hirsch, E C" sort="Hirsch, E C" uniqKey="Hirsch E" first="E. C." last="Hirsch">E. C. Hirsch</name>
</country>
<country name="Suède">
<noRegion>
<name sortKey="Karlsson, J O" sort="Karlsson, J O" uniqKey="Karlsson J" first="J. O." last="Karlsson">J. O. Karlsson</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000254 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000254 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:C99D9559849114DDA357418018F21B272E312E49
   |texte=   Increased m-calpain expression in the mesencephalon of patients with parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024